Role of oxidative modifications in atherosclerosis
- PMID: 15383655
- DOI: 10.1152/physrev.00047.2003
Role of oxidative modifications in atherosclerosis
Abstract
This review focuses on the role of oxidative processes in atherosclerosis and its resultant cardiovascular events. There is now a consensus that atherosclerosis represents a state of heightened oxidative stress characterized by lipid and protein oxidation in the vascular wall. The oxidative modification hypothesis of atherosclerosis predicts that low-density lipoprotein (LDL) oxidation is an early event in atherosclerosis and that oxidized LDL contributes to atherogenesis. In support of this hypothesis, oxidized LDL can support foam cell formation in vitro, the lipid in human lesions is substantially oxidized, there is evidence for the presence of oxidized LDL in vivo, oxidized LDL has a number of potentially proatherogenic activities, and several structurally unrelated antioxidants inhibit atherosclerosis in animals. An emerging consensus also underscores the importance in vascular disease of oxidative events in addition to LDL oxidation. These include the production of reactive oxygen and nitrogen species by vascular cells, as well as oxidative modifications contributing to important clinical manifestations of coronary artery disease such as endothelial dysfunction and plaque disruption. Despite these abundant data however, fundamental problems remain with implicating oxidative modification as a (requisite) pathophysiologically important cause for atherosclerosis. These include the poor performance of antioxidant strategies in limiting either atherosclerosis or cardiovascular events from atherosclerosis, and observations in animals that suggest dissociation between atherosclerosis and lipoprotein oxidation. Indeed, it remains to be established that oxidative events are a cause rather than an injurious response to atherogenesis. In this context, inflammation needs to be considered as a primary process of atherosclerosis, and oxidative stress as a secondary event. To address this issue, we have proposed an "oxidative response to inflammation" model as a means of reconciling the response-to-injury and oxidative modification hypotheses of atherosclerosis.
Similar articles
-
The expression and down stream effect of lectin like-oxidized low density lipoprotein 1 (LOX-1) in hyperglycemic state.Acta Med Indones. 2007 Jan-Mar;39(1):36-43. Acta Med Indones. 2007. PMID: 17939209 Review.
-
Review of human studies on oxidative damage and antioxidant protection related to cardiovascular diseases.Free Radic Res. 2000 Nov;33 Suppl:S85-97. Free Radic Res. 2000. PMID: 11191279 Review.
-
Low density lipoprotein oxidation and atherogenesis: from experimental models to clinical studies.G Ital Cardiol. 1997 Dec;27(12):1302-14. G Ital Cardiol. 1997. PMID: 9470066 Review.
-
[The significance of ixidized low density lipoprotein in atherosclerosis].Ugeskr Laeger. 1996 May 6;158(19):2706-10. Ugeskr Laeger. 1996. PMID: 8744072 Review. Danish.
-
Lipid oxidation and atherosclerosis.Herz. 1992 Oct;17(5):263-9. Herz. 1992. PMID: 1473812 Review.
Cited by
-
Lipid Oxidation Products and the Risk of Cardiovascular Diseases: Role of Lipoprotein Transport.Antioxidants (Basel). 2024 Apr 24;13(5):512. doi: 10.3390/antiox13050512. Antioxidants (Basel). 2024. PMID: 38790617 Free PMC article. Review.
-
A cross-sectional study exploring the relationship between oxidative balance score and 10-year atherosclerotic cardiovascular disease risk based on the National Health and Nutrition Examination Survey (2011-2020).Diab Vasc Dis Res. 2024 Mar-Apr;21(2):14791641241244658. doi: 10.1177/14791641241244658. Diab Vasc Dis Res. 2024. PMID: 38597578 Free PMC article.
-
Atherosclerosis: an overview of mouse models and a detailed methodology to quantify lesions in the aortic root.Vasc Biol. 2024 Apr 4;6(1):e230017. doi: 10.1530/VB-23-0017. Print 2024 Jan 1. Vasc Biol. 2024. PMID: 38428154 Free PMC article. Review.
-
Carbon Nanodots Inhibit Tumor Necrosis Factor-α-Induced Endothelial Inflammation through Scavenging Hydrogen Peroxide and Upregulating Antioxidant Gene Expression in EA.hy926 Endothelial Cells.Antioxidants (Basel). 2024 Feb 10;13(2):224. doi: 10.3390/antiox13020224. Antioxidants (Basel). 2024. PMID: 38397822 Free PMC article.
-
Enhancing CAR Macrophage Efferocytosis Via Surface Engineered Lipid Nanoparticles Targeting LXR Signaling.Adv Mater. 2024 May;36(19):e2308377. doi: 10.1002/adma.202308377. Epub 2024 Feb 22. Adv Mater. 2024. PMID: 38353580
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources